id,conversation_id,created_at,date,time,timezone,user_id,username,name,place,tweet,language,mentions,urls,photos,replies_count,retweets_count,likes_count,hashtags,cashtags,link,retweet,quote_url,video,thumbnail,near,geo,source,user_rt_id,user_rt,retweet_id,reply_to,retweet_date,translate,trans_src,trans_dest
976575004174405633,976575004174405633,2018-03-22 03:13:19 IST,2018-03-22,03:13:19,+0530,3063906311,juleenrzierath,Juleen R. Zierath,,"The European Foundation for the Study of Diabetes (EFSD), JDRF and Eli Lilly and Company (NYSE: LLY) have agreed to extend their collaboration for the European Programme in Type 1 Diabetes Research through 2020. @EASDnews @JDRFResearch @LillyPad #diabetes   https://t.co/BR3Hf9LZzc",en,"[{'screen_name': 'easdnews', 'name': 'easd', 'id': '79702114'}, {'screen_name': 'jdrfresearch', 'name': 'jdrf research', 'id': '971504962084712448'}, {'screen_name': 'lillypad', 'name': 'eli lilly and company', 'id': '172496840'}]",['http://markets.businessinsider.com/news/stocks/efsd-jdrf-and-lilly-extend-collaboration-supporting-type-1-diabetes-research-1018393644'],[],0,9,24,['diabetes'],[],https://twitter.com/JuleenRZierath/status/976575004174405633,False,,0,,,,,,,,[],,,,
